Literature DB >> 15691108

Use of bone morphogenetic proteins for musculoskeletal applications. An overview.

Michael A Mont1, Phillip S Ragland, Bridget Biggins, Gary Friedlaender, Tushar Patel, Stephen Cook, Gracia Etienne, Andrew Shimmin, Robyn Kildey, David C Rueger, Thomas A Einhorn.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15691108     DOI： 10.2106/00004623-200412002-00008

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN： 0021-9355            Impact factor:   5.284


× No keyword cloud information.
  21 in total

1.  Heparin-dopamine functionalized graphene foam for sustained release of bone morphogenetic protein-2.

Authors:  Qingqing Yao; Yangxi Liu; Hongli Sun
Journal:  J Tissue Eng Regen Med       Date:  2018-05-18       Impact factor: 3.963

2.  Correlation of computed tomography with histology in the assessment of periprosthetic defect healing.

Authors:  Stephen D Cook; Laura P Patron; Samantha L Salkeld; Kirk E Smith; Bruce Whiting; Robert L Barrack
Journal:  Clin Orthop Relat Res       Date:  2009-12       Impact factor: 4.176

3.  BBP-Functionalized Biomimetic Nanofibrous Scaffold Can Capture BMP2 and Promote Osteogenic Differentiation.

Authors:  Qingqing Yao; Eric S Sandhurst; Yangxi Liu; Hongli Sun
Journal:  J Mater Chem B       Date:  2017-05-30       Impact factor: 6.331

4.  Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2.

Authors:  Tien-Min G Chu; Stuart J Warden; Charles H Turner; Rena L Stewart
Journal:  Biomaterials       Date:  2006-09-25       Impact factor: 12.479

5.  A Pyk2 inhibitor incorporated into a PEGDA-gelatin hydrogel promotes osteoblast activity and mineral deposition.

Authors:  Sumana Posritong; Regina Flores Chavez; Tien-Min Gabriel Chu; Angela Bruzzaniti
Journal:  Biomed Mater       Date:  2019-02-27       Impact factor: 3.715

6.  Management of subtrochanteric femur fractures with internal fixation and recombinant human bone morphogenetic protein-7 in a patient with osteopetrosis: a case report.

Authors:  Robert D Golden; Edward K Rodriguez
Journal:  J Med Case Rep       Date:  2010-05-19

7.  Nonvascularized bone grafting defers joint arthroplasty in hip osteonecrosis.

Authors:  Thorsten M Seyler; David R Marker; Slif D Ulrich; Tobias Fatscher; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2008-05       Impact factor: 4.176

8.  Comparison between heparin-conjugated fibrin and collagen sponge as bone morphogenetic protein-2 carriers for bone regeneration.

Authors:  Hee Seok Yang; Wan-Geun La; Yong-Min Cho; Wangsoo Shin; Guw-Dong Yeo; Byung-Soo Kim
Journal:  Exp Mol Med       Date:  2012-05-31       Impact factor: 8.718

9.  Various Dosages of BMP-2 for Management of Massive Bone Defect in Sprague Dawley Rat.

Authors:  Achmad Fauzi Kamal; Othdeh Samuel Halomoan Siahaan; Jessica Fiolin
Journal:  Arch Bone Jt Surg       Date:  2019-11

10.  Tissue engineered strategies for pseudoarthrosis.

Authors:  Umile Giuseppe Longo; Ugo Trovato; Mattia Loppini; Giacomo Rizzello; Wasim Sardar Khan; Nicola Maffulli; Vincenzo Denaro
Journal:  Open Orthop J       Date:  2012-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.